Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Nanomaterials (Basel, Switzerland)|February 9, 2024
Titanium Dioxide Nanoparticles Doped with Iron for Water Treatment via Photocatalysis: A ReviewDomenico Rosa, Nigar Abbasova, Luca Di Palma
Heliyon|April 22, 2024
Functionalized biochar from waste as a slow-release nutrient source: Application on tomato plantsDomenico Rosa, Valerio Petruccelli, Maria Cristina Iacobbi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2008
Coligation of the hepatitis C virus receptor CD81 with CD28 primes naive T lymphocytes to acquire type 2 effector functionAlessandro Serra, Sandra Nuti, Simona Tavarini, et al.
The Journal of General Virology|September 20, 2000
Recombinant human monoclonal antibodies against different conformational epitopes of the E2 envelope glycoprotein of hepatitis C virus that inhibit its interaction with CD81Tobias Allander, Katarina Drakenberg, Aster Beyene, et al.
Plos One|June 13, 2015
Innate Response Activator (IRA) B Cells Reside in Human Tonsils and Internalize Bacteria In VitroNico Chiappini, Rocco Cantisani, Laura Pancotto, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 13, 2005
Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disordersDomenico Rosa, Giulietta Saletti, Ennio De Gregorio, et al.
Plos One|June 24, 2016
Early Rise of Blood T Follicular Helper Cell Subsets and Baseline Immunity as Predictors of Persisting Late Functional Antibody Responses to Vaccination in HumansFabiana Spensieri, Emilio Siena, Erica Borgogni, et al.
Vaccine|July 13, 2010
Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adultsSharon E Frey, Michael Houghton, Stephen Coates, et al.
Infection and Immunity|December 19, 2001
Genomic approach for analysis of surface proteins in Chlamydia pneumoniaeSilvia Montigiani, Fabiana Falugi, Maria Scarselli, et al.
The Journal of General Virology|July 19, 2006
Hepatitis C virus polyprotein vaccine formulations capable of inducing broad antibody and cellular immune responsesMichael Vajdy, Mark Selby, Angelica Medina-Selby, et al.
Pageof 2